Business | Press Trust of India | Tuesday December 1, 2015
Jubilant Life Sciences shares soared almost 10 per cent, to touch its fresh 52-week high on Tuesday, as the company received final approval from the US health regulator for its generic version of anti-depressant Paxil tablets.
www.ndtv.com/business